Hemorheological profile in primary and secondary Raynaud's phenomenon. Influence of microangiopathy

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Romagnoli M

Grupos

Abstract

Raynaud's phenomenon (RP) is an episodic peripheral circulatory disorder characterized by local artery spams in subjects exposed to cold or emotional stress. It is not well-established whether RP patients show an altered rheological profile, mostly due to patient classification and clinical severity. We aimed to compare the hemorheological profile in patients with primary and secondary RP with a healthy control group. Eighteen primary RP, 22 secondary RP and 22 healthy controls, were included in the study. RP patients were also divided according to the presence of digital ulcers (7 with, 33 without). Biochemical and hemorheological variables were analyzed, including glucose, triglycerides, total-cholesterol, immunoglobulins, fibrinogen, plasma viscosity, erythrocyte aggregation, erythrocyte deformability and blood viscosity. Age was higher in secondary RP as compared with primary (p=0.049), while glucose, triglycerides IgA, IgG and plasma viscosity were higher in secondary RP than in healthy subjects (p<0.05). RP patients with digital ulcers presented higher IgA (p=0.012), lower erythrocyte aggregation time (p=0.008) and a trend for higher fibrinogen levels and plasma viscosity (p=0.064, p=0.069, respectively). The results of the present study indicate that secondary RP patients show a mild impairment of the rheological profile that aggravates with microangiopathy severity.

Datos de la publicación

ISSN/ISSNe:
1386-0291, 1875-8622

CLINICAL HEMORHEOLOGY AND MICROCIRCULATION  IOS PRESS

Tipo:
Article
Páginas:
259-264
PubMed:
23609604
Factor de Impacto:
0,810 SCImago
Cuartil:
Q2 SCImago

Citas Recibidas en Web of Science: 4

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Raynaud's phenomenon; hemorheology; digital ulcers

Campos de Estudio

Proyectos y Estudios Clínicos

RED INVESTIGACION (RECAVA)

RD06/0014/0004 . INSTITUTO DE SALUD CARLOS III; FUNDACION PARA LA INV BIOMEDICA- HOSPITAL GREGORIO MARAÑON; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2006

RED CARDIOVASCULAR

Investigador Principal: FRANCISCO ESPAÑA FURIO

RD12/0042/0029 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013

ENSAYO CLINICO FASE III, DE GRUPOS PARALELOS, RANDOMIZADO, CONTROLADO CON PLACEBO, DOBLE CIEGO Y MULTICENTRICO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LA ADMINISTRACION DE TOCILIZUMAB EN PACIENTES DIAGNOSTICADOS DE ORBITOPATÍA TIROIDEA (OT) MODERADA A SE VERA O QUE AMENAZA LA VISTA, QUE NO HAN RESPONDIDO ADECUADAMENTE AL TRATAMIENTO CON PULSOS DE CORTICOIDES.

Investigador Principal: ENRIQUE ESPAÑA GREGORI

GRC-TCL-2010-01 . 2013

ESTUDIO OBSERVACIONAL TRANSVERSAL SOBRE LA LIMITACIÓN FUNCIONAL Y DE LAS ACTIVIDADES LABORALES Y DE LA VIDA DIARIA EN PACIENTES CON ESCLEROSIS SISTÉMICA QUE PRESENTAN O NO ÚLCERAS DIGITALES - ESTUDIO LAUDES.

Investigador Principal: JOSÉ ANTONIO TODOLÍ PARRA

ACT-NUL-2012-01

Cita

Compartir